Modified orbitozygomatic and far-lateral approaches adequately expose the midbasilar region and can replace transpetrosal approaches in some cases. These extended approaches can be associated with lower morbidity rates than can transpetrosal approaches. Hypothermic circulatory arrest is critical to clipping large and giant midbasilar artery aneurysms directly when approaches that conserve the temporal bone are used.
The presence of perilymph fistula has been difficult to determine because of the lack of efficient and reliable testing methods. The condition is suspected on the basis of history alone and confirmed by surgery. This paper details a quick, reliable procedure called the ENG fistula test, using impedance bridge for pressure change and electronystagmography to aid the establishment of nystagmus and dizziness. To evaluate this procedure, a combination of tests were performed, including Valsalva maneuver, tragal compression, and pneumatic otoscopy, which were previously considered helpful in the diagnosis of fistula. Of them, Valsalva maneuver and tragal compression proved inconclusive; pneumatic otoscopy proved to be helpful. In comparison, however, the ENG fistula test proved most valuable, with results surgically confirmed in 90.8% of cases in this series. This study involved 74 patients whose primary complaint was dizziness. Only some patients simultaneously experienced hearing lows. Included are 5 patients whose positive ENG fistula test results and 15 whose negative test results were confirmed by surgery. Selected case histories are presented.
The combination of the subtemporal and posterior fossa approaches has been used for many years to gain exposure of lesions in the clivus or medial petrous region. We have divided this approach, popularized by Malis, into three variations with progressively greater petrous bone resection to increase exposure of the clivus and medial petrous region. The approach has been divided into petrous bone resection with preservation of hearing (retrolabyrinthine), greater petrous bone resection with sacrifice of hearing (translabyrinthine), and, finally, maximum petrous drilling with sacrifice of hearing along with transposition of the facial nerve (transcochlear). By combining the skills of a neurosurgeon and a neuro-otologist, the operative exposure can be maximized. We present our experience with 30 cases of the combined approach, its variations, and its indications. METHODSThe surgical team consists of a neurosurgeon versed in skull base surgery and a neuro-otologist versed in all transmastoid-transcochlear procedures. The patient is positioned supine on the operating table with the head turned parallel to the floor and fixed to the operating table with the Mayfield headholder with appropriate shoulder support. The incision begins at the level of the zygoma 1 cm anterior to the ear and is continued in a gentle curving fashion around the ear to end just below the mastoid tip (Fig. 1). The incision can be modified by moving the posterior limb of the incision further posterior if greater exposure is necessary. The lateral side of the skull is exposed by retracting the scalp inferiorly with fish hooks. This maneuver exposes the zygoma, lateral temporal bone, external auditory meatus, and mastoid region. If more anterior exposure is required, the external auditory canal is transected and oversewn in two layers.The neuro-otologist performs the temporal bone approach using the Midas Rex (Midas Rex, Fort Worth, TX) high-speed drill system for the mastoidectomy portion and then changing to the Osteon (Hall Surgical, Santa Barbara, CA) system for more detailed bone removal under the operating microscope. Suction irrigation is used throughout. If hearing is to be preserved, an extended Skull
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.